Hormone Replacement Therapy
25
6
6
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 25 trials
100.0%
+13.5% vs benchmark
32%
8 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (25)
Menopause Effects on Cortico-reticular Functioning
Impact of New Hormone Replacement Therapy After Menopause on Heart Health in Women
Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
Investigation of the Perceptual and Acoustic Voice in Trans Man
Resting Energy Expenditure in Postmenopausal Women
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
HISTOLOGICAL RESULTS IN TRANSGENDER INDIVIDUALS ASSIGNED TO FEMALES AT BIRTH UNDERGOING GENDER AFFIRMATION SURGERY AND IN TESTOSTERONE THERAPY
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles
Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage
Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.
Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients
Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients
Menopausal Vaginal Microbiome
Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits
Estrogen Supplementation Mode in HRT-FET Cycle: a RCT
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
Development and Evaluation of a Hormone Replacement Therapy Decision-Aid